DK0572942T3 - Orale farmaceutiske præparater til specifik frigivelse i kolon - Google Patents

Orale farmaceutiske præparater til specifik frigivelse i kolon

Info

Publication number
DK0572942T3
DK0572942T3 DK93108658.1T DK93108658T DK0572942T3 DK 0572942 T3 DK0572942 T3 DK 0572942T3 DK 93108658 T DK93108658 T DK 93108658T DK 0572942 T3 DK0572942 T3 DK 0572942T3
Authority
DK
Denmark
Prior art keywords
oral pharmaceutical
colon
pharmaceutical preparations
specific release
core
Prior art date
Application number
DK93108658.1T
Other languages
English (en)
Other versions
DK0572942T4 (da
Inventor
Stefano Poli
Cesare Busetti
Luigi Moro
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11363431&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0572942(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Application granted granted Critical
Publication of DK0572942T3 publication Critical patent/DK0572942T3/da
Publication of DK0572942T4 publication Critical patent/DK0572942T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
DK93108658T 1992-06-01 1993-05-28 Orale farmaceutiske præparater til specifik frigivelse i kolon DK0572942T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921347A IT1260505B (it) 1992-06-01 1992-06-01 Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon

Publications (2)

Publication Number Publication Date
DK0572942T3 true DK0572942T3 (da) 1997-10-20
DK0572942T4 DK0572942T4 (da) 2001-01-22

Family

ID=11363431

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93108658T DK0572942T4 (da) 1992-06-01 1993-05-28 Orale farmaceutiske præparater til specifik frigivelse i kolon

Country Status (8)

Country Link
EP (1) EP0572942B2 (da)
AT (1) ATE151285T1 (da)
DE (1) DE69309540T3 (da)
DK (1) DK0572942T4 (da)
ES (1) ES2101164T5 (da)
GR (2) GR3023605T3 (da)
HU (1) HUT75158A (da)
IT (1) IT1260505B (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
US5686105A (en) * 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
ES2068762B1 (es) * 1993-07-21 1995-12-01 Lipotec Sa Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion.
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
GB9620709D0 (en) * 1996-10-04 1996-11-20 Danbiosyst Uk Colonic delivery of weak acid drugs
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
NL1009107C2 (nl) 1997-11-12 1999-06-15 Banner Pharmacaps Inc Gelatine-uitspreidende doos met meervoudige, aanpasbare poortklep en meerlagig zacht gel.
US6531152B1 (en) 1998-09-30 2003-03-11 Dexcel Pharma Technologies Ltd. Immediate release gastrointestinal drug delivery system
UA74141C2 (uk) 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
IL157634A0 (en) 2001-03-13 2004-03-28 Penwest Pharmaceuticals Co Chronotherapeutic dosage forms containing glucocorticosteroid
FR2830446B1 (fr) * 2001-10-09 2004-02-06 Univ Pasteur Composition pharmaceutique destinee a liberer une substance active au niveau du colon
BR0315731A (pt) * 2002-10-30 2005-09-06 Pharmacia Corp Comprimidos orais de liberação prolongada e métodos para fabricar e usar os mesmos
CU23334A1 (es) * 2003-03-20 2008-12-24 Inst Finlay Vacuna de vibrio cholerae inactivada en tabletas
BRPI0414311A (pt) 2003-09-19 2008-03-04 Penwest Pharmaceutical Co formas de dosagem de liberação controlada
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
ITMI20041295A1 (it) 2004-06-25 2004-09-25 Cosmo Spa Composizioni farmaceutiche antimicrobiche orali
EP1754471A1 (de) * 2005-08-18 2007-02-21 ORAMON-Arzneimittel GmbH & Co. KG Verwendung einer quellbaren Zwischenschicht zur Steuerung des Freisetzungsprofils einer festen Arzneimittelformulierung zur peroralen Anwendung und diese enthaltende Arzneimittelformulierung
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
WO2010000783A1 (de) * 2008-07-02 2010-01-07 Basf Se Verfahren zum beschichten von tabletten
IT1393244B1 (it) 2008-07-18 2012-04-12 Universita' Degli Studi Di Milano Sistema per il rilascio al colon di farmaci suscettibili di degradazione enzimatica e/o scarsamente assorbiti nel tratto gastrointestinale
US8283371B2 (en) 2009-01-14 2012-10-09 Novacta Biosystems Limited Compounds
EP2393829A1 (en) 2009-02-04 2011-12-14 Novacta Biosystems Limited Actagardine derivatives
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
WO2012013495A1 (en) 2010-07-29 2012-02-02 Cosmo Technologies Ltd. Pharmaceutical and/or dietary compositions based on short chain fatty acids
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
US20140227293A1 (en) 2011-06-30 2014-08-14 Trustees Of Boston University Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
KR20150140649A (ko) 2013-04-05 2015-12-16 폴리켐 에스.에이. 과민성 대장 증후군을 치료하기 위한 피도티모드의 사용
ES2900426T3 (es) 2013-12-31 2022-03-16 Rapamycin Holdings Llc Preparaciones orales y uso de nanopartículas de rapamicina
CA2968049A1 (en) 2014-04-16 2015-10-22 Rapamycin Holdings, Llc Oral rapamycin preparation and use for stomatitis
CN105943505A (zh) * 2016-05-26 2016-09-21 杭州百诚医药科技股份有限公司 一种匹多莫德药物组合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4891223A (en) * 1987-09-03 1990-01-02 Air Products And Chemicals, Inc. Controlled release delivery coating formulation for bioactive substances
IT1230576B (it) 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
US5032406A (en) † 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
PH27186A (en) † 1989-09-07 1993-04-16 Ciba Geigy Ag Double-coated granules of disodium pamidronate
DK469989D0 (da) † 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
IT1246382B (it) † 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon

Also Published As

Publication number Publication date
DK0572942T4 (da) 2001-01-22
ES2101164T3 (es) 1997-07-01
EP0572942B1 (en) 1997-04-09
GR3023605T3 (en) 1997-08-29
HU9301577D0 (en) 1993-09-28
ATE151285T1 (de) 1997-04-15
DE69309540D1 (de) 1997-05-15
EP0572942B2 (en) 2000-11-29
HUT75158A (en) 1997-04-28
DE69309540T2 (de) 1997-09-04
DE69309540T3 (de) 2001-03-15
IT1260505B (it) 1996-04-09
GR3035415T3 (en) 2001-05-31
ITMI921347A0 (it) 1992-06-01
EP0572942A2 (en) 1993-12-08
ES2101164T5 (es) 2001-02-01
ITMI921347A1 (it) 1993-12-02
EP0572942A3 (en) 1994-08-24

Similar Documents

Publication Publication Date Title
DK0572942T3 (da) Orale farmaceutiske præparater til specifik frigivelse i kolon
ATE9695T1 (de) Antihistamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE69923200D1 (de) Neue oral anzuwendende arzneizubereitungen für rivastigmine mit kontrollierter wirkstoffabgabe
FI933248A0 (fi) Optiskt aktiva 5h-pyrrolo(3,4-b)pyrazinderat, dess framstaellning och farmaceutiska kompositioner innehaollande detta
FI913248A0 (fi) Kontrollerat frigoerande fast farmaceutisk doseringsform.
ITBO910113A1 (it) Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
ATE235507T1 (de) Neue aminosäurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
DK1063995T3 (da) Kombination til behandling af alkoholafhængighed indeholdende en opiod-antagonist og en NMDA-receptorkompleks-modulator
DE68909412D1 (de) Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.
NO942952D0 (no) 11-benzaldoksin-17 ater, fremgangsmåte for deres fremstilling samt legemiddel inneholdende slike
ITFI930030A0 (it) Composti pirrol-amidinici, e loro sali farmaceuticamente accettabili, processi di preparazione e composizione farmaceutiche che li contengo-no.
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
NO884005L (no) Fluorerte derivater av aminosyrer saerlig for bruk som overflateaktive midler.
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
DE69104608D1 (de) Pharmazeutische Zubereitungen, Clavulansäure enthaltend, für die Behandlung der Periodontitis.
FI822671L (fi) Aminoglykosidderivat, foerfaranden foer framstaellning av dem, farmaceutiska kompositioner innehaollande dem samt anvaendning av saodana derivat som laekemedel
DK11089D0 (da) 2,5-diazabicyclooe2.2.1aaheptan-forbindelser, deres anvendelse til fremstilling af antiarytmi-laegemidler, farmaceutiske praeparater indeholdende forbindelserne samt forbindelse til anvendelse som udgangsmateriale ved deres fremstilling
ATE59551T1 (de) Feste orale arzneiformen mit gestaffelter wirkung zur verabreichung von wirkstoffen mit geschwuere erzeugender nebenwirkung.
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
ES2127305T3 (es) Una forma farmaceutica para la administracion rectal de compuestos farmacologicamente activos.
JPS51148017A (en) Controlling agents for slime
JPS5253830A (en) Preparation of optically active benzyl alcohol derivatives
ATE10934T1 (de) Peptid, verfahren zu dessen herstellung und dessen verwendung.
ATE2673T1 (de) Phenothiazinderivate, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung.
DE423151T1 (de) Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.